Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer

Clinical trial NCT03323658 · COMPLETED

Trial details

NCT number: NCT03323658
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Atypical Ductal Hyperplasia Breast Atypical Lobular Hyperplasia Breast Ductal Carcinoma In Situ Breast Lobular Carcinoma In Situ Invasive Breast Carcinoma

Start date: 2018-06-15
Primary completion: 2021-08-03
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.